Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Portillo's
PTLO
$365M
| $6.02M | ﹤0.01% |
378,116
+15,722
| +4% | +$243K |
|
2227
Diebold Nixdorf
DBD
$2.45B
| $6.01M | ﹤0.01% |
+207,716
| New | +$4.74M |
|
2228
Toyota
TM
$223B
| $6M | ﹤0.01% |
32,740
+9,191
| +39% | +$1.68M |
|
|
HAYN
2229
DELISTED
Haynes International, Inc.
HAYN
| $6M | ﹤0.01% |
105,137
+4,091
| +4% | +$197K |
|
2230
Full Truck Alliance
YMM
$9.2B
| $5.96M | ﹤0.01% |
850,413
-44,185
| -5% | -$312K |
|
|
RVNC
2231
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.95M | ﹤0.01% |
677,364
+13,826
| +2% | +$113K |
|
2232
Bank First Corp
BFC
$1.76B
| $5.94M | ﹤0.01% |
68,545
+1,007
| +1% | +$83.2K |
|
|
NKLA
2233
DELISTED
Nikola Corporation Common Stock
NKLA
| $5.91M | ﹤0.01% |
225,153
+50,418
| +29% | +$1.57M |
|
|
ETWO
2234
DELISTED
E2open Parent Holdings
ETWO
| $5.88M | ﹤0.01% |
1,340,465
+18,821
| +1% | +$66.8K |
|
2235
Regenxbio
RGNX
$704M
| $5.88M | ﹤0.01% |
327,451
+1,683
| +0.5% | +$29.6K |
|
2236
Arcturus Therapeutics
ARCT
$223M
| $5.87M | ﹤0.01% |
186,310
+2,369
| +1% | +$56.3K |
|
2237
International Money Express
IMXI
$353M
| $5.87M | ﹤0.01% |
265,611
+2,201
| +0.8% | +$42.2K |
|
2238
Old Second Bancorp
OSBC
$1.31B
| $5.86M | ﹤0.01% |
379,626
+10,827
| +3% | +$156K |
|
2239
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.25B
| $5.85M | ﹤0.01% |
91,753
-11,575
| -11% | -$698K |
|
2240
Hackett Group
HCKT
$277M
| $5.85M | ﹤0.01% |
256,795
+2,299
| +0.9% | +$52.1K |
|
2241
Artivion
AORT
$1.39B
| $5.83M | ﹤0.01% |
326,085
+8,090
| +3% | +$126K |
|
2242
Lifestance Health
LFST
$4.67B
| $5.83M | ﹤0.01% |
744,617
+5,112
| +0.7% | +$33K |
|
|
RAPT
2243
DELISTED
RAPT Therapeutics
RAPT
| $5.83M | ﹤0.01% |
29,305
+1,581
| +6% | +$196K |
|
2244
GoPro
GPRO
$117M
| $5.82M | ﹤0.01% |
1,677,795
+197,046
| +13% | +$625K |
|
2245
Anavex Life Sciences
AVXL
$303M
| $5.79M | ﹤0.01% |
622,310
+17,499
| +3% | +$120K |
|
2246
Atlas Energy Solutions
AESI
$1.47B
| $5.79M | ﹤0.01% |
336,324
+204,176
| +155% | +$3.76M |
|
2247
iShares National Muni Bond ETF
MUB
$45.9B
| $5.78M | ﹤0.01% |
53,285
-9,857
| -16% | -$1.03M |
|
2248
Arcos Dorados Holdings
ARCO
$1.71B
| $5.74M | ﹤0.01% |
452,203
-62,340
| -12% | -$668K |
|
2249
ImmunityBio
IBRX
$8.11B
| $5.74M | ﹤0.01% |
1,142,925
+92,991
| +9% | +$292K |
|
2250
Grid Dynamics Holdings
GDYN
$644M
| $5.72M | ﹤0.01% |
428,838
+431
| +0.1% | +$5.25K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.